According to the analysis of multiple databases about NAP1L1, the Conclusion showed that HCC patients with higher expression levels of NAP1L1 had a poorer prognosis than those with lower expression levels, and NAP1L1 is an independent prognostic factor for HCC. The gene discussed is NAP1L1; the disease is hepatocellular carcinoma.